ERIC I. RICHMAN - 01 Mar 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Dietrich A. Stephan, as attorney-in-fact for Eric I. Richman
Issuer symbol
NBSE
Transactions as of
01 Mar 2022
Transactions value $
$6,352
Form type
4
Filing time
07 Mar 2022, 18:13:35 UTC
Previous filing
17 Sep 2021
Next filing
23 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common stock Purchase $2.5K +1.58K +3.85% $1.58 42.7K 01 Mar 2022 Direct F1, F3
transaction NBSE Common stock Purchase $2.24K +1.3K +3.05% $1.72 44K 03 Mar 2022 Direct F1, F4
transaction NBSE Common stock Purchase $1.62K +1K +2.27% $1.62 45K 04 Mar 2022 Direct F1
holding NBSE Common stock 27.7K 01 Mar 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The power of attorney under which this form was signed is on file with the Commission.
F2 Shares are held in a trust for the benefit of the Reporting Person with the Reporting Person and the Reporting Person's spouse serving as co-trustees.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 These shares were purchased in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased in at each separate transaction.